Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Biden Offers Plan to Bolster U.S. Supply Chains in Crises

Published 2020-07-07, 12:00 p/m
© Bloomberg. Democratic presidential candidate former Vice President Joe Biden speaks at an an event about affordable healthcare at the Lancaster Recreation Center on June 25, 2020 in Lancaster, Pennsylvania.

(Bloomberg) -- Democratic nominee Joe Biden laid out a plan Tuesday aimed at bolstering U.S. supply-chain capabilities to reduce reliance on foreign countries in times of crises.

The plan, which packages many of the policies Biden has already called for in responding to the coronavirus pandemic, includes invoking the Defense Production Act to speed up production of urgent medical supplies, using federal purchasing power to bolster domestic manufacturing capacity and bolstering the supply chain for pharmaceuticals.

If elected, Biden would also initiate a 100-day review of national security risks across America’s international supply chains.

The goal of the plan is to increase domestic production, expand strategic stockpiles and have surge capacity during national emergencies. Senior Biden officials said the plan is not aimed at self-sufficiency but rather “broad-based resiliency.”

The focus on supply chains comes as the U.S. has faced shortages of critical medical supplies amid a global pandemic that has killed more than 130,000 Americans. Biden has been unsparing in his criticism of President Donald Trump’s stewardship of the crisis, faulting him for acting too slowly in responding and saying he has “surrendered” in the fighting the virus.

Biden’s plan also calls for using the Biomedical Advanced Research and Development Authority to spur medical production. And it would leverage federal health care purchases and reform the tax code to encourage pharmaceutical companies to make key drugs and medical devices in the U.S.

©2020 Bloomberg L.P.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.